Medical Xpress
Blood gene test detects 90% of early-stage pancreatic cancers
Kanazawa University researchers have developed a blood-based gene expression test capable of detecting 90% of early-stage pancreatic cancers — a disease notorious for its late diagnosis and grim survival rates. The breakthrough could transform screening protocols for one of medicine's most elusive killers. If validated at scale, it may give clinicians a rare window to intervene before the cancer becomes untreatable.
Read article →Guardian Health
Reducing ultra-processed foods could prevent thousands of heart disease deaths, study suggests
Cutting ultra-processed foods from diets could prevent thousands of cardiovascular deaths, according to new Canadian modelling research that links junk food consumption to up to a third of heart disease cases. The findings position UPFs — including ready meals, fizzy drinks, and fast food — as a "substantial and potentially preventable" driver of one of the world's leading killers. As UPF consumption continues to rise globally, researchers say the public health stakes of dietary habits have never been higher.
Read article →Guardian Health
All newborns in England to be screened for spinal muscular atrophy from 2027
England will begin screening all newborns for spinal muscular atrophy (SMA) from 2027, the Department of Health and Social Care has confirmed. The rare muscle-wasting condition, if caught early, can be treated before symptoms emerge — potentially sparing affected children a lifetime of serious disability. Campaigners are calling it a landmark shift in how the disease is managed, with early intervention now set to become the standard of care.
Read article →New Scientist Health
Next generation Alzheimer’s drug reduces risk of serious brain bleeds
A next-generation antibody drug has shown it can slow Alzheimer's progression while significantly reducing the risk of serious brain bleeds, one of the most dangerous side effects associated with current treatments. The drug's improved ability to cross the blood-brain barrier allows it to work more efficiently at lower doses, limiting the vascular damage linked to existing therapies. For the millions living with Alzheimer's, this could mark a meaningful step toward treatments that are both effective and safer to sustain long-term.
Read article →Medical Xpress
Experimental pancreatic cancer vaccine elicits durable immune responses in high-risk participants
An experimental vaccine targeting pancreatic ductal adenocarcinoma has demonstrated durable immune responses in high-risk individuals carrying hereditary cancer-susceptibility mutations. The trial focuses on a population particularly vulnerable to one of oncology's most lethal diagnoses, where a five-year survival rate remains stubbornly low and late-stage detection is common. Intervening at the precursor lesion stage could mark a significant shift in how clinicians approach prevention in genetically predisposed patients.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →